180 Life Sciences Issues Letter to Stockholders
PALO ALTO, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...
Healthcare
Biofrontera Inc.’s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer Awards
WOBURN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...
TFF Pharmaceuticals to Participate in the Roth Inaugural Healthcare Opportunities Conference
FORT WORTH, Texas, Sept. 26, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing...
eFFECTOR Therapeutics Appoints Mayank Gandhi, M.D., as Chief Business Officer
SAN DIEGO and REDWOOD CITY, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in...
SomaLogic’s Chief Medical Officer Steve Williams honored with C-Suite Award by the Denver Business Journal
BOULDER, Colo., Sept. 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced...
Daxor Corporation to Exhibit at the Annual Scientific Meeting of the Heart Failure Society of America
Compelling New Patient Outcome Data to be Presented Oak Ridge, TN, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:...
Secure Transfusion Solutions Announces it will Present New Data and Participate at the 2022 AABB Annual Meeting
AUSTIN, Texas, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Secure Transfusion Solutions (STS), a private life sciences company pioneering innovative solutions...
Immutep to Participate in Two Upcoming Investor Conferences
SYDNEY, AUSTRALIA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage...
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from Petrichor
~ Under the Terms of the Previously Announced Investment Agreement, $5 Million Already Funded Upon Initial Closing, Which Occurred on...
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader...
Rhythm Pharmaceuticals Announces Publication of Children’s Book for Patients and Families Living with Bardet-Biedl Syndrome (BBS)
Understanding Hunger & Bardet-Biedl Syndrome (BBS): Gabe’s Story Developed in collaboration with the Bardet-Biedl Syndrome (BBS) Foundation-- Book developed in...
Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th
SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling...
Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada
Optimi aiming to become the first vertically integrated psychedelics firm to formulate and trial MDMA for healthy subjectsVANCOUVER, British Columbia,...
Bicycle Health Announces $5 Million Investment From Cobalt Ventures to Scale Its Virtual Opioid Use Disorder Treatment
BOSTON, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Bicycle Health, the leading provider of virtual opioid addiction treatment, today announced an...
BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module
Company to introduce the most advanced iteration of its signal processing technology at Cleveland Clinic’s Global EP Summit 2022, a...
Quad M Solutions Announces Appointment of CFO Squad to Assist with Financial Reporting and Accounting Automation
Garland, TX, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Quad M Solutions, Inc. (OTC: MMMM) a staffing company providing modern health...
Vericel to Present at the Ladenburg Thalmann Healthcare Conference
CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences
WALTHAM, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology...
Albireo Announces $115 Million Royalty Monetization Agreement with Sagard
Upfront payment for continued clinical development and commercialization of Bylvay®Sagard to receive a mid-single digit average royalty rate on Bylvay...
MediWound Announces Concurrent Registered Direct and Private Placement Offerings Priced At-the-Market of Approximately $30 Million
YAVNE, Israel, Sept. 22, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a fully integrated biopharmaceutical company focused...
